XML 15 R6.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - UNAUDITED - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Accumulated Earnings
Balance, beginning of period, shares at Dec. 31, 2023   29,541,000        
Balance, beginning of period at Dec. 31, 2023 $ 273,326 $ 713 $ 490,947 $ (1,136,055) $ (50,413) $ 968,134
Net Income (Loss) 19,467         19,467
Foreign currency translation adjustments (4,975)       (4,975)  
Total comprehensive income 14,492          
Repurchase of common stock, shares   (344,000)        
Repurchase of common stock (18,223) $ (2) (8,538) (9,683)    
Issuance of common stock pursuant to employee stock purchase plan 866   866      
Issuance of common stock pursuant to employee stock purchase plan, shares   20,000        
Issuance of restricted common stock pursuant to stock-based compensation plans, shares   573,000        
Issuance of restricted common stock pursuant to stock-based compensation plans   $ 6 (6)      
Cancellation of restricted common stock issued pursuant to stock-based compensation plans, shares   (11,000)        
Stock-based compensation expense 7,736   7,736      
Dividends (8,857)         (8,857)
Balance, ending of period, shares at Mar. 31, 2024   29,779,000        
Balance, ending of period at Mar. 31, 2024 $ 269,340 $ 717 491,005 (1,145,738) (55,388) 978,744
Balance, beginning of period, shares at Dec. 31, 2024 28,854,000 28,854,000        
Balance, beginning of period at Dec. 31, 2024 $ 282,569 $ 718 518,215 (1,194,224) (62,290) 1,020,150
Net Income (Loss) 16,130         16,130
Foreign currency translation adjustments 6,823       6,823  
Total comprehensive income 22,953          
Repurchase of common stock, shares   (358,000)        
Repurchase of common stock (22,236) $ (2) (12,807) (9,427)    
Issuance of common stock pursuant to employee stock purchase plan 769 $ 0 769 0    
Issuance of common stock pursuant to employee stock purchase plan, shares   15,000        
Issuance of restricted common stock pursuant to stock-based compensation plans, shares   608,000        
Issuance of restricted common stock pursuant to stock-based compensation plans   $ 6 (6)      
Cancellation of restricted common stock issued pursuant to stock-based compensation plans, shares   (15,000)        
Stock-based compensation expense 8,404   8,404      
Dividends $ (9,364)         (9,364)
Balance, ending of period, shares at Mar. 31, 2025 29,104,000 29,104,000        
Balance, ending of period at Mar. 31, 2025 $ 283,095 $ 722 $ 514,575 $ (1,203,651) $ (55,467) $ 1,026,916